Inspire Medical Systems vs Tandem Diabetes Care
Inspire Medical Systems and Tandem Diabetes Care are similar in size: $912m and $1.01bn of revenue in their latest fiscal years. Inspire Medical Systems grew faster (13.6% against 7.9%). Inspire Medical Systems kept more of each dollar of sales as profit: a net margin of 15.9% against -20.2%. Inspire Medical Systems carries less debt relative to equity (0.0% against 199.8%).
| Latest fiscal year | Inspire Medical SystemsINSP, 2025 | Tandem Diabetes CareTNDM, 2025 |
|---|---|---|
| Revenue | $912m | $1.01bn |
| Revenue growth | 13.6% | 7.9% |
| Net income | $145m | −$205m |
| Operating margin | 5.6% | -18.5% |
| Net margin | 15.9% | -20.2% |
| Return on equity | 19.8% | -97.9% |
| Free cash flow | $78.5m | −$29.7m |
| Cash | $105m | $90.6m |
| Total debt | $0 | $310m |
| Debt to equity | 0.0% | 199.8% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $175m | $0 |
| Employees | 1,333 | 2,500 |
| Market value | $1.80bn | $1.23bn |
| Price vs our value range | — | — |
| Moat score | 39 (Weak) | 30 (Weak) |
| Insider trades, 12 months | 0 buys, 7 sales | 0 buys, 3 sales |